Logo
Subscribe Now

All Posts by Date

Kaia Health Offers a Complete Musculoskeletal Care Solution with Kaia Gateway and Premium Partners

Kaia Health Offers a Complete Musculoskeletal Care Solution with Kaia Gateway and Premium Partners

Galapagos and Gilead Discontinue the P-III Trials of Ziritaxestat (GLPG1690) for Idiopathic Pulmonary Fibrosis

Galapagos and Gilead Discontinue the P-III Trials of Ziritaxestat (GLPG1690) for Idiopathic Pulmonary Fibrosis

Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value

Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value

AbbVie Signs a License Agreement with Caribou Biosciences for CAR-T Cell Therapies

AbbVie Signs a License Agreement with Caribou Biosciences for CAR-T Cell Therapies

Sanofi Collaborates with i2O Therapeutics to Evaluate Oral i2O Therapeutics

Sanofi Collaborates with i2O Therapeutics to Evaluate Oral i2O Therapeutics

AstraZeneca Signs Letter of Intent with IDT Biologika to Boost COVID-19 Vaccine Manufacturing Capability in the EU

AstraZeneca Signs Letter of Intent with IDT Biologika to Boost COVID-19 Vaccine Manufacturing Capability in the EU

Image

Stay Connected

We Have a Viewership of 1,00,000 + Views

Join the PharmaShot Family

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2021 PharmaShots - All Rights Reserved.